ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610457; 2) Community: the network communities that were significantly associated with the response to NSC 610457; 3) Molecule: the relationships between components within communities and NSC 610457; 4) MDR: the compounds that were significantly associated with the NSC 610457.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 2.73683969415353e-006 0.93237152
NSC 660027 Null 3.31921050119507e-005 0.54573579
NSC 683555 Camptothecin Derivative 5.09419714526527e-005 0.89229044
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 5.30973832161747e-005 0.77904456
NSC 644960 Null 6.70485325419773e-005 0.6672509
NSC 606498 Camptothecin Derivative 6.70485325419777e-005 0.79580508
NSC 609699 Topotecan hydrochloride 6.70485325419777e-005 0.93376757
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 6.74487631170141e-005 0.67584422
NSC 759878 Irinotecan hydrochloride (USAN) 6.74487631170141e-005 0.89039893
NSC 94600 Camptothecin 9.17168114922265e-006 0.93372384
Total:58  Current:58    [First] [Prev] [Next] [Last]